Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 39.10% is 145% above its 5-year average of -86.70%, near the high end of its 5-year range (-146.40%–39.10%).
207.82% above its 12-month average of -36.27%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -1.86%.
RETURN ON ASSETS (ROA)
39.10%
RETURN ON ASSETS (ROA) AVG TTM
-36.27%
RETURN ON ASSETS (ROA) AVG 3Y
-59.86%
RETURN ON ASSETS (ROA) AVG 5Y
-86.70%
RETURN ON ASSETS (ROA) AVG 10Y
-308.36%
RETURN ON ASSETS (ROA) AVG 15Y
-327.26%
RETURN ON ASSETS (ROA) AVG 20Y
-339.22%
CURRENT VS TTM AVG
+207.82%
CURRENT VS 3Y AVG
+165.32%
CURRENT VS 5Y AVG
+145.10%
CURRENT VS 10Y AVG
+112.68%
CURRENT VS 15Y AVG
+111.95%
CURRENT VS 20Y AVG
+111.53%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+221.28%
vs the sector median at left
SANUWAVE Health Inc.
Market Cap
$44.71M
Return on Assets (ROA)
39.10%
TTM Avg
-36.27%
3Y Avg
-59.86%
5Y Avg
-86.70%
Market Cap
$44.72M
Return on Assets (ROA)
-143.30%
TTM Avg
-71.59%
3Y Avg
-49.53%
5Y Avg
-40.25%
Market Cap
$44.02M
Return on Assets (ROA)
70.17%
TTM Avg
-36.93%
3Y Avg
-46.92%
5Y Avg
-57.84%
Market Cap
$45.73M
Return on Assets (ROA)
-71.66%
TTM Avg
-64.58%
3Y Avg
-65.51%
5Y Avg
-55.75%
Market Cap
$42.99M
Return on Assets (ROA)
-56.31%
TTM Avg
-47.91%
3Y Avg
-41.18%
5Y Avg
-35.79%
Market Cap
$42.83M
Return on Assets (ROA)
-128.10%
TTM Avg
-35.87%
3Y Avg
-35.25%
5Y Avg
-29.40%
Market Cap
$46.69M
Return on Assets (ROA)
-15.32%
TTM Avg
-31.60%
3Y Avg
-39.35%
5Y Avg
-32.49%
Market Cap
$42.72M
Return on Assets (ROA)
-87.60%
TTM Avg
-55.36%
3Y Avg
-44.79%
5Y Avg
-43.77%
Market Cap
$42.26M
Return on Assets (ROA)
-40.69%
TTM Avg
-38.43%
3Y Avg
-19.21%
5Y Avg
-15.37%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SANUWAVE Health Inc. (SNWV) | $44.71M | 39.10% | -36.27% | -59.86% | -86.70% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | -143.30% | -71.59% | -49.53% | -40.25% |
| DarioHealth Corp. (DRIO)vs › | $44.02M | 70.17% | -36.93% | -46.92% | -57.84% |
| Celularity Inc. (CELU)vs › | $45.73M | -71.66% | -64.58% | -65.51% | -55.75% |
| CVRx, Inc. (CVRX)vs › | $42.99M | -56.31% | -47.91% | -41.18% | -35.79% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -128.10% | -35.87% | -35.25% | -29.40% |
| Instil Bio, Inc. (TIL)vs › | $46.69M | -15.32% | -31.60% | -39.35% | -32.49% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | -87.60% | -55.36% | -44.79% | -43.77% |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | -40.69% | -38.43% | -19.21% | -15.37% |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | -57.95% | 4.78% | -64.05% | -66.64% |
ROA
39.1%
ROE
513.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 31.63% |
| 2024-12-31 | -104.16% |
| 2023-12-31 | -115.13% |
| 2022-12-31 | -51.79% |
| 2021-12-31 | -146.40% |
| 2020-12-31 | -134.35% |
| 2019-12-31 | -308.39% |
| 2018-12-31 | -987.61% |
| 2017-12-31 | -433.05% |
| 2016-12-31 | -640.78% |
| 2015-12-31 | -501.93% |
| 2014-12-31 | -128.02% |
| 2013-12-31 | -711.54% |
| 2012-12-31 | -345.93% |
| 2011-12-31 | -166.05% |
| 2010-12-31 | -492.60% |
| 2009-12-31 | -104.87% |
| 2008-12-31 | -823.00% |
| 2007-12-31 | -693.18% |
| 2006-12-31 | 72.75% |
